Market Overview:
The global live beneficial bacteria market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for animal-based products, rising awareness about the benefits of probiotics, and growing demand for organic food products. Based on type, the global live beneficial bacteria market can be segmented into dry and liquid probiotics. The dry segment is expected to account for a larger share of the market than the liquid segment during the forecast period. This can be attributed to factors such as ease of storage and transportation, longer shelf life, and lower price point as compared to liquid probiotics. Based on application, the global live beneficial bacteria market can be divided into poultry, swine, ruminants aquaculture animals), and others (including equine). The poultry segment is projected to account for a larger share of this market than other segments during 2018-2030 owing high consumption rates in countries such as China India) . However ,the ruminants sector is anticipated witness highest CAGR over th e forecast period due t o increasin g demand fo r organi c beef an d lamb i n developed countrie s .
Product Definition:
Live Beneficial Bacteria are bacteria that live in the gut and provide health benefits. They help to break down food, synthesize vitamins, and regulate the immune system. They are important for overall health and can be helpful in treating a variety of conditions.
Dry:
Dry is a term used for bacteria that do not grow or multiply in the presence of water. The most commonly known dry beneficial bacteria are lactic acid producing bacteria, probiotics and prebiotics producing Bifidobacteria and Streptococcus Thermophilus.
Liquid:
Liquid is a live beneficial bacteria. It is used in the probiotic food and beverage industry to provide health benefits beyond basic nutritional value of food. The liquid form of bacteria can be added to any product including dairy, cereals, juices, etc., which provides it an additional advantage over its dry form counterpart.
The global market for probiotics is growing at a rapid pace with increasing awareness among consumers regarding the products that promote long term good health.
Application Insights:
Poultry was the largest application segment in 2017 and is expected to continue its dominance over the forecast period. Live beneficial bacteria are added to feed of poultry animals in order to improve their health and performance. These products help stimulate bacterial growth in the animal's gut, which helps break down food into energy, thus improving weight gain of livestock. The addition of these products also improves feed efficiency by increasing weight gains per unit of feed consumed by livestock thereby reducing wastage caused due to uneaten food intake as well as increasing productivity.
The swine segment is expected register a significant CAGR during the forecast period owing to rising demand for pork from emerging economies such as China, India.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to witness a CAGR of XX% over the forecast period, owing to high animal health awareness and presence of well-established livestock farms in this region. Moreover, increasing demand for meat products is also anticipated to propel the growth of live beneficial bacteria industry in North America over the forecast period.
Asia Pacific is projected to be one of the fastest-growing regional markets from 2018 to 2030 due its rapidly growing population coupled with rising disposable income levels and expanding livestock farms across rural areas as well as urban centers.
The live beneficial bacteria industry has witnessed significant development across Central & South American countries such as Brazil.
Growth Factors:
- Increasing awareness about the benefits of probiotics for human health is driving the growth of the live beneficial bacteria market.
- The increasing incidence of lifestyle diseases, such as obesity, diabetes, and heart disease is fueling demand for probiotics supplements as a preventive measure.
- The growing popularity of fermented foods and beverages is also contributing to the growth of the live beneficial bacteria market.
- Rising consumer expenditure on personal care products is propelling demand for probiotic-based skin and hair care products.
- Growing research on the use of probiotics in various applications is providing a boost to the live beneficial bacteria market
Scope Of The Report
Report Attributes
Report Details
Report Title
Live Beneficial Bacteria Market Research Report
By Type
Dry, Liquid
By Application
Poultry, Swine, Ruminants, Aquatic animals, Others
By Companies
Archer Daniels Midland Company, E.I. Dupont De Nemours and Company, Koninklijke DSM N.V., Novozymes, Chr. Hansen Holding A/S, Kemin Industries, Inc., Biomin Holding GmbH, Lallemand, Inc., Novus International, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Live Beneficial Bacteria Market Report Segments:
The global Live Beneficial Bacteria market is segmented on the basis of:
Types
Dry, Liquid
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Poultry, Swine, Ruminants, Aquatic animals, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Archer Daniels Midland Company
- E.I. Dupont De Nemours and Company
- Koninklijke DSM N.V.
- Novozymes
- Chr. Hansen Holding A/S
- Kemin Industries, Inc.
- Biomin Holding GmbH
- Lallemand, Inc.
- Novus International, Inc.
Highlights of The Live Beneficial Bacteria Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Dry
- Liquid
- By Application:
- Poultry
- Swine
- Ruminants
- Aquatic animals
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Live Beneficial Bacteria Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Live Beneficial Bacteria is a probiotic supplement that contains live bacteria that helps improve your digestion.
Some of the major players in the live beneficial bacteria market are Archer Daniels Midland Company, E.I. Dupont De Nemours and Company, Koninklijke DSM N.V., Novozymes, Chr. Hansen Holding A/S, Kemin Industries, Inc., Biomin Holding GmbH, Lallemand, Inc., Novus International, Inc..
The live beneficial bacteria market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Live Beneficial Bacteria Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Live Beneficial Bacteria Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Live Beneficial Bacteria Market - Supply Chain
4.5. Global Live Beneficial Bacteria Market Forecast
4.5.1. Live Beneficial Bacteria Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Live Beneficial Bacteria Market Size (000 Units) and Y-o-Y Growth
4.5.3. Live Beneficial Bacteria Market Absolute $ Opportunity
5. Global Live Beneficial Bacteria Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Live Beneficial Bacteria Market Size and Volume Forecast by Type
5.3.1. Dry
5.3.2. Liquid
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Live Beneficial Bacteria Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Live Beneficial Bacteria Market Size and Volume Forecast by Application
6.3.1. Poultry
6.3.2. Swine
6.3.3. Ruminants
6.3.4. Aquatic animals
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Live Beneficial Bacteria Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Live Beneficial Bacteria Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Live Beneficial Bacteria Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Live Beneficial Bacteria Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Live Beneficial Bacteria Demand Share Forecast, 2019-2026
9. North America Live Beneficial Bacteria Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Live Beneficial Bacteria Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Live Beneficial Bacteria Market Size and Volume Forecast by Application
9.4.1. Poultry
9.4.2. Swine
9.4.3. Ruminants
9.4.4. Aquatic animals
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Live Beneficial Bacteria Market Size and Volume Forecast by Type
9.7.1. Dry
9.7.2. Liquid
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Live Beneficial Bacteria Demand Share Forecast, 2019-2026
10. Latin America Live Beneficial Bacteria Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Live Beneficial Bacteria Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Live Beneficial Bacteria Market Size and Volume Forecast by Application
10.4.1. Poultry
10.4.2. Swine
10.4.3. Ruminants
10.4.4. Aquatic animals
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Live Beneficial Bacteria Market Size and Volume Forecast by Type
10.7.1. Dry
10.7.2. Liquid
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Live Beneficial Bacteria Demand Share Forecast, 2019-2026
11. Europe Live Beneficial Bacteria Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Live Beneficial Bacteria Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Live Beneficial Bacteria Market Size and Volume Forecast by Application
11.4.1. Poultry
11.4.2. Swine
11.4.3. Ruminants
11.4.4. Aquatic animals
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Live Beneficial Bacteria Market Size and Volume Forecast by Type
11.7.1. Dry
11.7.2. Liquid
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.0. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Live Beneficial Bacteria Demand Share, 2019-2026
12. Asia Pacific Live Beneficial Bacteria Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Live Beneficial Bacteria Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Live Beneficial Bacteria Market Size and Volume Forecast by Application
12.4.1. Poultry
12.4.2. Swine
12.4.3. Ruminants
12.4.4. Aquatic animals
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Live Beneficial Bacteria Market Size and Volume Forecast by Type
12.7.1. Dry
12.7.2. Liquid
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Live Beneficial Bacteria Demand Share, 2019-2026
13. Middle East & Africa Live Beneficial Bacteria Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Live Beneficial Bacteria Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Live Beneficial Bacteria Market Size and Volume Forecast by Application
13.4.1. Poultry
13.4.2. Swine
13.4.3. Ruminants
13.4.4. Aquatic animals
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Live Beneficial Bacteria Market Size and Volume Forecast by Type
13.7.1. Dry
13.7.2. Liquid
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Live Beneficial Bacteria Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Live Beneficial Bacteria Market: Market Share Analysis
14.2. Live Beneficial Bacteria Distributors and Customers
14.3. Live Beneficial Bacteria Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Archer Daniels Midland Company
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. E.I. Dupont De Nemours and Company
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Koninklijke DSM N.V.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Novozymes
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Chr. Hansen Holding A/S
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Kemin Industries, Inc.
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Biomin Holding GmbH
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Lallemand, Inc.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Novus International, Inc.
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
